$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | Astellas Pharma Inc. | 10% Owner | Buy | P | 57.50 | 6,387,295 | 367,269,463 | 57,232,357 | 50.8 M to 57.2 M (+12.56 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Sell | U | 57.50 | 622 | 35,765 | 0 | 622 to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Sell | D | 57.50 | 280 | 16,100 | 0 | 280 to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Sell | U | 57.50 | 736 | 42,320 | 280 | 1 K to 280 (-72.44 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | U | 57.50 | 5,500 | 316,250 | 0 | 5.5 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Sell | U | 57.50 | 11,490 | 660,675 | 0 | 11.5 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Sell | U | 57.50 | 2,125 | 122,188 | 0 | 2.1 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Sell | U | 57.50 | 5,342 | 307,165 | 0 | 5.3 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | U | 57.50 | 375 | 21,563 | 0 | 375 to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Sell | U | 57.50 | 910 | 52,325 | 0 | 910 to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Sell | U | 57.50 | 1,675 | 96,313 | 0 | 1.7 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | D | 57.50 | 5,000 | 287,500 | 0 | 5 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | D | 57.50 | 8,500 | 488,750 | 0 | 8.5 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Sell | D | 57.50 | 750 | 43,125 | 0 | 750 to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | U | 57.50 | 4,175 | 240,063 | 0 | 4.2 K to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Sell | U | 57.50 | 8 | 460 | 0 | 8 to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | Davies Angela M. | Sr. VP and CMO, Onc ... | Sell | D | 57.50 | 16 | 920 | 0 | 16 to 0 (-100.00 %) |
Jun 09 2010 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Sell | U | 57.50 | 6,500 | 373,750 | 0 | 6.5 K to 0 (-100.00 %) |
Jun 08 2010 | OSIP | OSI PHARMACEUTICAL ... | Astellas Pharma Inc. | 10% Owner | Buy | P | 57.50 | 1,176,026 | 67,621,495 | 50,845,062 | 49.7 M to 50.8 M (+2.37 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 35.40 | 24,000 | 849,600 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 33.62 | 60,000 | 2,017,200 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 47.29 | 22,000 | 1,040,380 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 37.74 | 11,250 | 424,575 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 29.77 | 15,000 | 446,550 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 38.01 | 21,850 | 830,519 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 67.63 | 17,200 | 1,163,236 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 30.74 | 23,600 | 725,464 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 21.55 | 2,300 | 49,565 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | D | 45.01 | 44,000 | 1,980,440 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Payment of Exercise | F | 57.50 | 514 | 29,555 | 1,016 | 1.5 K to 1 K (-33.59 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Sell | U | 57.50 | 19,044 | 1,095,030 | 1,530 | 20.6 K to 1.5 K (-92.56 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Sell | D | 57.50 | 20,105 | 1,156,038 | 20,574 | 40.7 K to 20.6 K (-49.42 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | D | 36.25 | 3,000 | 108,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | D | 28.65 | 7,500 | 214,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | D | 38.63 | 7,500 | 289,725 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | D | 30.39 | 3,000 | 91,170 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | D | 45.60 | 7,500 | 342,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | D | 82.88 | 50,000 | 4,144,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Sell | D | 57.50 | 750 | 43,125 | 5,342 | 6.1 K to 5.3 K (-12.31 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Sell | D | 57.50 | 4,375 | 251,563 | 6,092 | 10.5 K to 6.1 K (-41.80 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Option Exercise | D | 35.40 | 20,000 | 708,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Option Exercise | D | 33.62 | 25,000 | 840,500 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Option Exercise | D | 47.29 | 11,250 | 532,013 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Option Exercise | D | 37.74 | 8,000 | 301,920 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Option Exercise | D | 23.83 | 2,717 | 64,746 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Option Exercise | D | 46.93 | 22,000 | 1,032,460 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Sell | D | 57.50 | 12,278 | 705,985 | 0 | 12.3 K to 0 (-100.00 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Sell | U | 57.50 | 2,124 | 122,130 | 12,278 | 14.4 K to 12.3 K (-14.75 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 35.40 | 15,000 | 531,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 33.62 | 36,000 | 1,210,320 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 47.29 | 16,500 | 780,285 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 37.74 | 15,000 | 566,100 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 29.77 | 15,000 | 446,550 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 38.01 | 18,720 | 711,547 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 67.63 | 17,000 | 1,149,710 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 30.74 | 12,483 | 383,727 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | D | 35.88 | 20,000 | 717,500 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 57.50 | 628 | 36,110 | 622 | 1.3 K to 622 (-50.24 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Sell | D | 57.50 | 13,500 | 776,250 | 1,250 | 14.8 K to 1.3 K (-91.53 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Sell | U | 57.50 | 12,616 | 725,420 | 14,750 | 27.4 K to 14.8 K (-46.10 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | D | 28.65 | 7,500 | 214,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | D | 38.63 | 7,500 | 289,725 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | D | 36.25 | 3,000 | 108,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | D | 30.39 | 3,000 | 91,170 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | D | 47.34 | 50,000 | 2,367,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | D | 28.65 | 7,500 | 214,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | D | 38.63 | 3,000 | 115,890 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | D | 36.25 | 3,000 | 108,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | D | 30.39 | 25,000 | 759,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Sell | D | 57.50 | 5,500 | 316,250 | 2,125 | 7.6 K to 2.1 K (-72.13 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Sell | U | 57.50 | 16,375 | 941,563 | 7,625 | 24 K to 7.6 K (-68.23 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Option Exercise | D | 28.65 | 3,000 | 85,950 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Option Exercise | D | 38.63 | 3,000 | 115,890 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Option Exercise | D | 36.25 | 25,000 | 906,250 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Sell | D | 57.50 | 11,500 | 661,250 | 0 | 11.5 K to 0 (-100.00 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 28.65 | 7,500 | 214,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 38.63 | 7,500 | 289,725 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 36.25 | 3,000 | 108,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 30.39 | 3,000 | 91,170 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 45.60 | 15,000 | 684,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 38.61 | 15,000 | 579,150 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 15.02 | 2,769 | 41,590 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | D | 41.38 | 20,000 | 827,600 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | D | 57.50 | 4,375 | 251,563 | 375 | 4.8 K to 375 (-92.11 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | D | 57.50 | 1,500 | 86,250 | 4,750 | 6.3 K to 4.8 K (-24.00 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | U | 57.50 | 80,001 | 4,600,058 | 6,250 | 86.3 K to 6.3 K (-92.75 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 28.65 | 7,500 | 214,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 38.63 | 7,500 | 289,725 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 36.25 | 3,000 | 108,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 30.39 | 3,000 | 91,170 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 45.60 | 7,500 | 342,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 38.61 | 7,500 | 289,575 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 15.02 | 6,000 | 90,120 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 41.38 | 7,500 | 310,350 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | D | 36.13 | 10,000 | 361,250 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | U | 57.50 | 12,823 | 737,323 | 5,500 | 18.3 K to 5.5 K (-69.98 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | D | 28.65 | 7,500 | 214,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | D | 38.63 | 3,000 | 115,890 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | D | 36.25 | 2,250 | 81,563 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | D | 30.39 | 12,500 | 379,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | D | 57.50 | 5,500 | 316,250 | 8,500 | 14 K to 8.5 K (-39.29 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Option Exercise | D | 33.62 | 22,500 | 756,450 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Option Exercise | D | 35.40 | 11,250 | 398,250 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Option Exercise | D | 47.29 | 17,500 | 827,575 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Option Exercise | D | 37.74 | 4,000 | 150,960 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Option Exercise | D | 26.21 | 7,084 | 185,672 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Sell | U | 57.50 | 3,531 | 203,033 | 8 | 3.5 K to 8 (-99.77 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Sell | D | 57.50 | 9,809 | 564,018 | 3,539 | 13.3 K to 3.5 K (-73.49 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | D | 35.40 | 20,000 | 708,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | D | 33.62 | 48,000 | 1,613,760 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | D | 47.29 | 22,000 | 1,040,380 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | D | 37.74 | 20,000 | 754,800 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | D | 29.77 | 5,000 | 148,850 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | D | 38.01 | 30,000 | 1,140,300 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | D | 48.30 | 40,000 | 1,932,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Sell | D | 57.50 | 17,892 | 1,028,790 | 1,675 | 19.6 K to 1.7 K (-91.44 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Sell | U | 57.50 | 11,056 | 635,720 | 19,567 | 30.6 K to 19.6 K (-36.10 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | D | 28.65 | 7,500 | 214,875 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | D | 38.63 | 3,000 | 115,890 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | D | 36.25 | 3,000 | 108,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | D | 30.39 | 25,000 | 759,750 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Sell | U | 57.50 | 7,500 | 431,250 | 6,500 | 14 K to 6.5 K (-53.57 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 35.40 | 135,000 | 4,779,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 33.62 | 135,000 | 4,538,700 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 47.29 | 62,500 | 2,955,625 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 37.74 | 37,500 | 1,415,250 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 29.77 | 50,000 | 1,488,500 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 38.01 | 46,960 | 1,784,950 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 67.63 | 50,000 | 3,381,500 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 30.74 | 60,700 | 1,865,918 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 21.55 | 51,430 | 1,108,317 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 51.80 | 45,000 | 2,331,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | D | 23.25 | 34,000 | 790,500 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | D | 57.50 | 67,382 | 3,874,465 | 4,175 | 71.6 K to 4.2 K (-94.17 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | U | 57.50 | 86,708 | 4,985,710 | 71,557 | 158.3 K to 71.6 K (-54.79 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | D | 28.65 | 10,000 | 286,500 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | D | 38.63 | 10,000 | 386,300 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | D | 36.25 | 6,000 | 217,500 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | D | 30.39 | 6,000 | 182,340 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | D | 45.60 | 15,000 | 684,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | D | 38.61 | 15,000 | 579,150 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | D | 16.92 | 25,000 | 423,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Sell | D | 57.50 | 11,000 | 632,500 | 750 | 11.8 K to 750 (-93.62 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Sell | U | 57.50 | 18,136 | 1,042,820 | 11,750 | 29.9 K to 11.8 K (-60.68 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 35.40 | 20,000 | 708,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 33.62 | 48,000 | 1,613,760 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 47.29 | 18,000 | 851,220 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 37.74 | 20,000 | 754,800 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 29.77 | 20,000 | 595,400 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 38.01 | 36,430 | 1,384,704 | 0 |